Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 2]

View source ↗

Summary

Phase 2 trial to evaluate the efficacy and safety of DA-2811 added to BT-1 and BT-2 therapy in adults with Type 2 diabetes and inadequate glycemic control; not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BT-1
• BT-2
• DA-2811 (DA-2811)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Diabete Mellitus | Phase 2 | Status: NOT_YET_RECRUITING